GlaxoSmithKline pays $25 million to Synta for reaching melanoma drug goals
LEXINGTON, Mass. GlaxoSmithKline has paid biotech Synta Pharmaceuticals $25 million for reaching operational milestones for the melanoma drug elesclomol, Synta announced Tuesday.
Synta could receive an additional $25 million in operational milestone payments before completion of enrollment of the SYMMETRY trial, and another $25 million after enrollment is finished if the trial meets the primary endpoint or if the two companies agree to apply for regulatory approval for the drug, which is in phase 3 testing.
In total, the agreement between the two companies calls for $585 million in development and regulatory milestone payments related to melanoma and other cancer indications.
Walgreens ships diabetes supplies for free to Medicare Part B patients
DEERFIELD, Ill. Walgreens has announced that it ship diabetes testing supplies for free to people who have their supplies covered under Medicare Part B.
The move comes at a time when budgets are tight—especially for seniors. To make getting diabetes supplies easier and more affordable, Walgreens said, patients can pick up their testing items at one of the 6,400 stores or have supplies mailed to their home at no cost.
Those seniors who are eligible can sign up by calling 1-888-PARTB-65 (1-888-727-8265) or request a call from a Walgreens representative by logging on to https://www.walgreens.com/partb. Special Walgreens phone reps will assist with filing all of the necessary Part B claim forms and will answer any other additional questions, the company said.
Bruno’s, Food World stores announce closings of many in-store pharmacies
TUSCALOOSA, Ala. Bruno’s over the weekend announced that 22 out 40 in-store pharmacies in Bruno’s and Food World stored throughout Alabama and Florida will be closed. The closures will affect about 60 employees, the company said.
Bruno’s will sell remaining prescriptions and pharmaceutical inventories to CVS, a spokesman told the local media. CVS may also retain some of Bruno’s pharmacy employees.
No word yet on what Bruno’s will do with the remaining space in stores.